the total amount paid out in life claims was £129.4m, with £13.46m paid in terminal illness claims.
.
.
.
. taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said.
.: "fremanezumab for the preventive treatment of chronic migraine."
.